An independent review board has cast doubt on the findings for AstraZeneca's coronavirus vaccine candidate, saying the drugmaker's efficacy claims may have been based on outdated data.
The post Safety Board Wary of AstraZeneca's COVID Vaccine Trial Data appeared first on The Washington Informer.
